MARKET

AIM

AIM

Aim Immunotech
AMEX
0.2523
-0.0024
-0.94%
Opening 12:44 08/12 EDT
OPEN
0.2546
PREV CLOSE
0.2547
HIGH
0.2546
LOW
0.2461
VOLUME
646.23K
TURNOVER
--
52 WEEK HIGH
2.890
52 WEEK LOW
0.2100
MARKET CAP
7.68M
P/E (TTM)
-0.0341
1D
5D
1M
3M
1Y
5Y
1D
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR)
TipRanks · 4h ago
AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article
Barchart · 9h ago
AIM ImmunoTech CEO Urges Biodefense Military Integration
TipRanks · 1d ago
AIM ImmunoTech Reports Q2 Loss, Topline Phase 2 Pancreatic Cancer Data Due In Q1 2027
NASDAQ · 2d ago
AIM ImmunoTech GAAP EPS of -$0.43
Seeking Alpha · 2d ago
AIM ImmunoTech Q2 EPS $(0.43) Misses $(0.18) Estimate, Sales $26.000K Up From $25.000K YoY
Benzinga · 2d ago
Press Release: AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen(R) Toward Planned Phase 3 Development in Pancreatic Cancer
Dow Jones · 2d ago
*AIM ImmunoTech 2Q Loss/Shr 43c >AIM
Dow Jones · 2d ago
More
About AIM
AIM ImmunoTech Inc. is an immuno-pharma company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) and highly selective TLR3 agonist immuno-modulator, which is being developed for globally important cancers, viral diseases and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS). Alferon N Injection is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Webull offers AIM ImmunoTech Inc stock information, including AMEX: AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.